You can buy or sell SLP and other stocks, options, ETFs, and crypto commission-free!
Simulations Plus, Inc. engages in licensing and conducting drug research by pharmaceutical and biotechnology companies. It offers pharmaceutical, and chemical, cosmetics and food industries. Read More The company was founded by Walter S. Woltosz and Virginia E. Woltosz on July 17, 1996 and is headquartered Lancaster, CA.
52 Week High
52 Week Low
Yahoo FinanceMay 9
Simulations Plus (NASDAQ:SLP) Shareholders Have Enjoyed A Whopping 304% Share Price Gain
Want to participate in a short research study? Help shape the future of investing tools and you could win a $250 gift card! Buying shares in the best businesses can build meaningful wealth for you and your family. While not every stock performs well, when investors win, they can win big. To wit, the Simulations Plus, Inc. (NASDAQ:SLP) share price has soared 304% over five years. If that doesn't get you thinking about long term investing, we don't know what will. On top of that, the share price is up 21% in...
Simply Wall StMay 7
How Much Of Simulations Plus, Inc. (NASDAQ:SLP) Do Insiders Own?
Want to participate in a short research study? Help shape the future of investing tools and you could win a $250 gift card! The big shareholder groups in Simulations Plus, Inc. (NASDAQ:SLP) have power over the company. Generally speaking, as a company grows, institutions will increase their ownership. Conversely, insiders often decrease their ownership over time. I generally like to see some degree of insider ownership, even if only a little. As Nassim Nicholas Taleb said, ‘Don’t tell me what you think, te...
Yahoo FinanceMay 1
Lisa LaVange, PhD, Appointed to Board of Directors of Simulations Plus
LANCASTER, Calif.--(BUSINESS WIRE)-- Brings 35+ Years of Industry and Regulatory Expertise to Board Simulations Plus, Inc. (SLP), the premier provider of simulation and modeling software and consulting services for all stages of pharmaceutical discovery and development, today announced the appointment of Dr. Lisa LaVange to the Company’s Board of Directors. With a distinguished career spanning more than 35 years, Dr. LaVange brings expertise in biostatistics and experience with academia, commercial organi...
Expected Jul 9, After Hours